Vanguard Group’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.47M | Sell |
4,734,013
-1,155,180
| -20% | -$359K | ﹤0.01% | 3637 |
|
2025
Q1 | $2.88M | Buy |
5,889,193
+340,962
| +6% | +$167K | ﹤0.01% | 3363 |
|
2024
Q4 | $4.75M | Buy |
5,548,231
+305,282
| +6% | +$261K | ﹤0.01% | 3292 |
|
2024
Q3 | $44.6M | Sell |
5,242,949
-79,511
| -1% | -$676K | ﹤0.01% | 2227 |
|
2024
Q2 | $24.9M | Buy |
5,322,460
+2,312,170
| +77% | +$10.8M | ﹤0.01% | 2459 |
|
2024
Q1 | $20.5M | Sell |
3,010,290
-220,191
| -7% | -$1.5M | ﹤0.01% | 2584 |
|
2023
Q4 | $10.8M | Buy |
3,230,481
+1,801,827
| +126% | +$6.04M | ﹤0.01% | 2901 |
|
2023
Q3 | $3.56M | Buy |
1,428,654
+431,652
| +43% | +$1.07M | ﹤0.01% | 3388 |
|
2023
Q2 | $1.28M | Buy |
997,002
+141,847
| +17% | +$182K | ﹤0.01% | 3824 |
|
2023
Q1 | $694K | Buy |
855,155
+58,593
| +7% | +$47.5K | ﹤0.01% | 4021 |
|
2022
Q4 | $605K | Buy |
796,562
+343,299
| +76% | +$261K | ﹤0.01% | 4048 |
|
2022
Q3 | $422K | Sell |
453,263
-60,956
| -12% | -$56.8K | ﹤0.01% | 4258 |
|
2022
Q2 | $488K | Sell |
514,219
-96,648
| -16% | -$91.7K | ﹤0.01% | 4303 |
|
2022
Q1 | $1.29M | Sell |
610,867
-240,271
| -28% | -$507K | ﹤0.01% | 4129 |
|
2021
Q4 | $7.62M | Buy |
851,138
+839
| +0.1% | +$7.51K | ﹤0.01% | 3380 |
|
2021
Q3 | $14.1M | Buy |
850,299
+5,417
| +0.6% | +$89.9K | ﹤0.01% | 3052 |
|
2021
Q2 | $17.6M | Buy |
844,882
+10,713
| +1% | +$223K | ﹤0.01% | 2915 |
|
2021
Q1 | $15.6M | Buy |
834,169
+152,605
| +22% | +$2.86M | ﹤0.01% | 2920 |
|
2020
Q4 | $15M | Buy |
681,564
+887
| +0.1% | +$19.5K | ﹤0.01% | 2782 |
|
2020
Q3 | $14.1M | Buy |
680,677
+65,157
| +11% | +$1.35M | ﹤0.01% | 2611 |
|
2020
Q2 | $22.3M | Buy |
615,520
+67,462
| +12% | +$2.44M | ﹤0.01% | 2370 |
|
2020
Q1 | $17.9M | Buy |
548,058
+208,162
| +61% | +$6.81M | ﹤0.01% | 2346 |
|
2019
Q4 | $9.27M | Buy |
339,896
+304,932
| +872% | +$8.32M | ﹤0.01% | 2895 |
|
2019
Q3 | $384K | Buy |
+34,964
| New | +$384K | ﹤0.01% | 3868 |
|